"A new agreement between the Trump administration and drug manufacturer Pfizer will exempt the giant from proposed pharmaceutical tariffs in exchange for allegedly cutting price for American consumers. The deal has inspired Trump to declare victory over Pfizer, telling CEO Albert Bourla, “I’m surprised you’re agreeing to this.”
However, on closer inspection, the deal appears to be more of a bailout for Pfizer than the American people, with broad promises of sweeping drug savings that, in typical Trump fashion, are unfounded.
Pfizer and Trump’s team-up came as a reported “blindside” to other pharmaceutical companies facing pressure to fall in line and buddy up with the administration before it imposes additional tariffs.
The deal, which sent Pfizer’s stock soaring, is well timed: Pfizer estimates it will lose upward of $18 billion in annual revenue by 2028 as the patents for four of its major pharmaceutical products expire, and generic versions enter the market."
https://jacobin.com/2025/10/pfizer-bourla-trump-pharma-prices-dtc/
#USA #Trump #Pfizer #BigPharma #Patents #Generics